A pioneering preclinical study has shown that CAR T cell therapy-a personalized form of immunotherapy used in cancer ...

The National Institute for Health and Care Excellence (NICE) has approved a chimeric antigen receptor (CAR) T-cell therapy for adults with large B-cell lymphoma. The treatment significantly delays ...

CD19 chimeric antigen receptor (CAR) T-cell therapy showed potential in treating patients with refractory systemic lupus erythematosus (SLE), with B-cell depletion and disease activity reduction ...

Explore the breakthrough of new CAR-T cell therapy for glioblastoma, offering hope against one of the deadliest brain cancers.

BENGALURU: Experts at a global symposium on cell therapy hosted by Ramaiah Memorial Hospital & Healthcare Services said on ...

About 18 years ago, a 4-year-old girl with a rare nerve cell cancer received an infusion of immune cells that were genetically engineered to fight the disease. Since then, she has remained cancer-free ...

Johnson & Johnson and Legend Biotech are said to have withdrawn an abstract originally planned for next month’s Amer | “At this point, the abstract was withdrawn in alignment with the authors, and we ...